background and overview[1] 7-bromobenzofuran-2-carboxylic acid can be used as a pharmaceutical synthesis intermediate. preparation[1] method 1: the pr…
background and overview[1] heterocyclic compounds, especially natural products containing furan and thiophene structures, mostly have good biological …
background and overview[1] 2,5-dimethoxyphenylethylamine is the main raw material for the synthesis of 5-hydroxytryptamine (5-ht) compounds. its main …
background and overview[1] heterocyclic compounds are widely found in nature, accounting for about half of organic compounds. 2-aminothiazole ring der…
background and overview[1] 2-fluorophene ether can be used as a pharmaceutical synthesis intermediate. if 2-fluorophenylethyl ether is inhaled, please…
background and overview[1] 3-(1-pyrrolidinyl)benzaldehyde can be used as a pharmaceutical synthesis intermediate. preparation[1] the preparation of (1…
background and overview[1] butyl phthalyl glycolate is an ester derivative and can be used as a pharmaceutical synthesis intermediate. structure prepa…
background and overview[1] 3-(3-iodo)phenylacetic acid can be used as a pharmaceutical synthesis intermediate. if 3-(3-iodo)phenylacetic acid is inhal…
background and overview[1] 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine can be used as a pharmaceutical synthesis intermediate. if 3,5-diethyl-1,…
background and overview[1] diphenylthiocarbazine is a hydrazine derivative, which can be used as a pharmaceutical synthesis intermediate. for example,…
overview[1] chroman-2-one is a tyrosinase inhibitor suitable for lightening human skin or for the prevention and/or treatment of pigment defects such …
background and overview[1] eltrombopag (trade name: promacta) was developed by the british company glaxosmithkline. it was approved by the fda for mar…